Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study

BackgroundStudies have shown that there may be dissimilar perceptions on symptoms or side effects between patients with cancer and health care professionals. This may lead to symptomatic patients notifying the clinic irregularly or not telling the clinic at all. Wearables cou...

Full description

Bibliographic Details
Main Authors: Emma Balch Steen-Olsen, Helle Pappot, Allan Green, Henning Langberg, Cecilie Holländer-Mieritz
Format: Article
Language:English
Published: JMIR Publications 2022-10-01
Series:JMIR Research Protocols
Online Access:https://www.researchprotocols.org/2022/10/e37626
_version_ 1797734738972114944
author Emma Balch Steen-Olsen
Helle Pappot
Allan Green
Henning Langberg
Cecilie Holländer-Mieritz
author_facet Emma Balch Steen-Olsen
Helle Pappot
Allan Green
Henning Langberg
Cecilie Holländer-Mieritz
author_sort Emma Balch Steen-Olsen
collection DOAJ
description BackgroundStudies have shown that there may be dissimilar perceptions on symptoms or side effects between patients with cancer and health care professionals. This may lead to symptomatic patients notifying the clinic irregularly or not telling the clinic at all. Wearables could help identify symptoms earlier. Patients with low socioeconomic status and less self-awareness of their health may benefit from this. A new design of wearables is a smart t-shirt that, with embedded sensors, provides measurement flows such as electrocardiogram, thoracic and abdominal respiration, and temperature. ObjectiveThis study evaluates the feasibility of using a smart t-shirt for home monitoring of biometric sensor data in adolescent and young adult and elderly patients during cancer treatment. MethodsThe OncoSmartShirt study is an explorative study investigating the feasibility of using the Chronolife smart t-shirt during cancer treatment. This smart t-shirt is designed with multiple fully embedded sensors and electrodes that engender 6 different measurement flows continuously. A total of 20 Danish patients with cancer ≥18 years old in antineoplastic treatment at Department of Oncology Rigshospitalet Denmark will be recruited from all cancer wards, whether patients are in curative or palliative care. Of these 20 patients, 10 (50%) will be <39 years old, defined as adolescent and young adult, and 10 (50%) will be patients >65 years old, defined as elderly. Consenting patients will be asked to wear a smart t-shirt daily for 2 weeks during their treatment course. ResultsThe primary outcome is to determine if it is feasible to wear a smart t-shirt throughout the day (preferably 8 hours per day) for 2 weeks. Inclusion of patients started in March 2022. ConclusionsThe study will assess the feasibility of using the Chronolife smart t-shirt for home monitoring of vital parameters in patients with cancer during their treatment and bring new insights into how wearables and biometric data can be used as part of symptom or side-effect recognition in patients with cancer during treatment, with the aim to increase patients’ quality of life. Trial RegistrationClinicalTrials.gov NCT05235594; https://beta.clinicaltrials.gov/study/NCT05235594 International Registered Report Identifier (IRRID)PRR1-10.2196/37626
first_indexed 2024-03-12T12:47:45Z
format Article
id doaj.art-b7d1436b4b97404fb2c60767572cef04
institution Directory Open Access Journal
issn 1929-0748
language English
last_indexed 2024-03-12T12:47:45Z
publishDate 2022-10-01
publisher JMIR Publications
record_format Article
series JMIR Research Protocols
spelling doaj.art-b7d1436b4b97404fb2c60767572cef042023-08-28T23:12:09ZengJMIR PublicationsJMIR Research Protocols1929-07482022-10-011110e3762610.2196/37626Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt StudyEmma Balch Steen-Olsenhttps://orcid.org/0000-0003-2022-7897Helle Pappothttps://orcid.org/0000-0002-3570-5372Allan Greenhttps://orcid.org/0000-0002-4156-9207Henning Langberghttps://orcid.org/0000-0001-8454-6534Cecilie Holländer-Mieritzhttps://orcid.org/0000-0002-0724-5540 BackgroundStudies have shown that there may be dissimilar perceptions on symptoms or side effects between patients with cancer and health care professionals. This may lead to symptomatic patients notifying the clinic irregularly or not telling the clinic at all. Wearables could help identify symptoms earlier. Patients with low socioeconomic status and less self-awareness of their health may benefit from this. A new design of wearables is a smart t-shirt that, with embedded sensors, provides measurement flows such as electrocardiogram, thoracic and abdominal respiration, and temperature. ObjectiveThis study evaluates the feasibility of using a smart t-shirt for home monitoring of biometric sensor data in adolescent and young adult and elderly patients during cancer treatment. MethodsThe OncoSmartShirt study is an explorative study investigating the feasibility of using the Chronolife smart t-shirt during cancer treatment. This smart t-shirt is designed with multiple fully embedded sensors and electrodes that engender 6 different measurement flows continuously. A total of 20 Danish patients with cancer ≥18 years old in antineoplastic treatment at Department of Oncology Rigshospitalet Denmark will be recruited from all cancer wards, whether patients are in curative or palliative care. Of these 20 patients, 10 (50%) will be <39 years old, defined as adolescent and young adult, and 10 (50%) will be patients >65 years old, defined as elderly. Consenting patients will be asked to wear a smart t-shirt daily for 2 weeks during their treatment course. ResultsThe primary outcome is to determine if it is feasible to wear a smart t-shirt throughout the day (preferably 8 hours per day) for 2 weeks. Inclusion of patients started in March 2022. ConclusionsThe study will assess the feasibility of using the Chronolife smart t-shirt for home monitoring of vital parameters in patients with cancer during their treatment and bring new insights into how wearables and biometric data can be used as part of symptom or side-effect recognition in patients with cancer during treatment, with the aim to increase patients’ quality of life. Trial RegistrationClinicalTrials.gov NCT05235594; https://beta.clinicaltrials.gov/study/NCT05235594 International Registered Report Identifier (IRRID)PRR1-10.2196/37626https://www.researchprotocols.org/2022/10/e37626
spellingShingle Emma Balch Steen-Olsen
Helle Pappot
Allan Green
Henning Langberg
Cecilie Holländer-Mieritz
Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study
JMIR Research Protocols
title Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study
title_full Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study
title_fullStr Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study
title_full_unstemmed Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study
title_short Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study
title_sort feasibility of monitoring patients who have cancer with a smart t shirt protocol for the oncosmartshirt study
url https://www.researchprotocols.org/2022/10/e37626
work_keys_str_mv AT emmabalchsteenolsen feasibilityofmonitoringpatientswhohavecancerwithasmarttshirtprotocolfortheoncosmartshirtstudy
AT hellepappot feasibilityofmonitoringpatientswhohavecancerwithasmarttshirtprotocolfortheoncosmartshirtstudy
AT allangreen feasibilityofmonitoringpatientswhohavecancerwithasmarttshirtprotocolfortheoncosmartshirtstudy
AT henninglangberg feasibilityofmonitoringpatientswhohavecancerwithasmarttshirtprotocolfortheoncosmartshirtstudy
AT ceciliehollandermieritz feasibilityofmonitoringpatientswhohavecancerwithasmarttshirtprotocolfortheoncosmartshirtstudy